JointReliveX is a daily joint-support capsule combining 8 ingredients -- glucosamine sulfate, boswellia extract, chondroitin sulfate, turmeric root, quercetin, MSM, bromelain, and methionine -- taken as a 2-capsule daily serving.
This is the one question JointReliveX's own materials don't answer consistently. The sales page suggests results 'often' build within 4 to 8 weeks; a separate FAQ mentions many customers noticing reduced morning stiffness within 2 to 4 weeks; and the brand separately recommends 90 to 180 days of consistent use for its stated 'best results.' Treat these as a general range rather than a single promise.
Per 2-capsule serving: Glucosamine Sulfate 1,000mg, Boswellia Extract 133.3mg, Chondroitin Sulfate 100mg, Turmeric Root 100mg, Quercetin 16.7mg, MSM 16.7mg, Bromelain 16.7mg, and Methionine 16.7mg, based on label data reviewed from the brand's own materials.
Not entirely. Glucosamine and Boswellia are reasonably in line with common research amounts. Chondroitin (100mg) and Quercetin (16.7mg) sit well below the amounts most often used in the studies cited for those specific ingredients.
This is a question for your doctor. Bromelain and turmeric are both commonly flagged in general pharmacology literature for potential interactions with blood-thinning and antiplatelet medications.
Glucosamine is commonly sourced from shellfish across the supplement industry, though this specific product's sourcing wasn't confirmed in the materials we reviewed. If you have a shellfish allergy, confirm sourcing with the brand directly before ordering.
Two vegetable capsules daily, per the label's stated serving size.
JointReliveX is backed by a 60-day money-back guarantee. Notably, the brand's stated policy doesn't require returning the bottles to receive a refund -- confirm this detail directly with support before relying on it.
JointReliveX's packages are sold as one-time multi-bottle purchases based on the materials we reviewed; confirm this at checkout.
JointReliveX is manufactured in the United States. Fulfillment is handled out of a facility in Aurora, Colorado.